Document is current

Any future updates will be listed below

Immunoinformatics-guided approach to target CISD2 upregulation using (2R)-2-[3,4-bis(oxidanyl)phenyl]-6-oxidanyl-2,3-dihydrochromen-4-one(6J6) for treating chronic kidney disease: enhancing CISD2 upregulation to combat CKD through 6J6

Crossref DOI link: https://doi.org/10.1007/s40203-025-00479-2

Published Online: 2025-12-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark